Common Name |
Isoleucyl-Valine
Description |
Isoleucyl-Valine is a dipeptide composed of isoleucine and valine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.
Structure |
MOLSDF3D-SDFPDBSMILESInChI View 3D Structure
Structure for HMDB28920 (Isoleucyl-Valine)
Synonyms |
Value |
Source |
I-V dipeptideHMDB
Ile-valHMDB
Isoleucine valine dipeptideHMDB
Isoleucine-valine dipeptideHMDB
IsoleucylvalineHMDB
IV dipeptideHMDB
L-Isoleucyl-L-valineHMDB
Chemical Formlia |
C11H22N2O3
Average Molecliar Weight |
230.304
Monoisotopic Molecliar Weight |
230.16304258
IUPAC Name |
2-(2-amino-3-methylpentanamido)-3-methylbutanoic acid
Traditional Name |
2-(2-amino-3-methylpentanamido)-3-methylbutanoic acid
CAS Registry Number |
Not Available
SMILES |
CCC(C)C(N)C(=O)NC(C(C)C)C(O)=O
InChI Identifier |
InChI=1S/C11H22N2O3/c1-5-7(4)8(12)10(14)13-9(6(2)3)11(15)16/h6-9H,5,12H2,1-4H3,(H,13,14)(H,15,16)
InChI Key |
BCXBIONYYJCSDF-UHFFFAOYSA-N
Chemical Taxonomy |
Description |
This compound belongs to the class of chemical entities known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond.
Kingdom |
Chemical entities
Super Class |
Organic compounds
Class |
Organic acids and derivatives
Sub Class |
Carboxylic acids and derivatives
Direct Parent |
Dipeptides
Alternative Parents |
Isoleucine and derivatives
Valine and derivatives
N-acyl-alpha amino acids
Alpha amino acid amides
Methyl-branched fatty acids
N-acyl amines
Secondary carboxylic acid amides
Amino acids
Monocarboxylic acids and derivatives
Carboxylic acids
Organopnictogen compounds
Organic oxides
Monoalkylamines
Hydrocarbon derivatives
Carbonyl compounds
Substituents |
Alpha-dipeptide
Isoleucine or derivatives
N-acyl-alpha-amino acid
Valine or derivatives
N-acyl-alpha amino acid or derivatives
Alpha-amino acid amide
Alpha-amino acid or derivatives
Branched fatty acid
Methyl-branched fatty acid
N-acyl-amine
Fatty amide
Fatty acid
Fatty acyl
Amino acid or derivatives
Secondary carboxylic acid amide
Carboxamide group
Amino acid
Carboxylic acid
Monocarboxylic acid or derivatives
Organic nitrogen compound
Organonitrogen compound
Primary aliphatic amine
Organooxygen compound
Primary amine
Hydrocarbon derivative
Carbonyl group
Organic oxide
Organopnictogen compound
Amine
Organic oxygen compound
Aliphatic acyclic compound
Molecliar Framework |
Aliphatic acyclic compounds
External Descriptors |
Not Available
Ontology |
Status |
Expected but not Quantified
Origin |
Endogenous
Biofunction |
Not Available
Application |
Not Available
Cellliar locations |
Not Available
Physical Properties |
State |
Solid
Experimental Properties |
Property |
Value |
Reference |
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogP-1.16Extrapolated
Predicted Properties |
Property |
Value |
Source |
Water Solubility9.89 mg/mLALOGPS
logP-1.1ALOGPS
logP-1.2ChemAxon
logS-1.4ALOGPS
pKa (Strongest Acidic)4.06ChemAxon
pKa (Strongest Basic)8.51ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count4ChemAxon
Hydrogen Donor Count3ChemAxon
Polar Surface Area92.42 Å2ChemAxon
Rotatable Bond Count6ChemAxon
Refractivity60.39 m3·mol-1ChemAxon
Polarizability25.15 Å3ChemAxon
Number of Rings0ChemAxon
Bioavailability1ChemAxon
Rlie of FiveYesChemAxon
Ghose FilterYesChemAxon
Vebers RlieYesChemAxon
MDDR-like RlieYesChemAxon
Spectra |
Spectra |
Not Available
Biological Properties |
Cellliar Locations |
Not Available
Biofluid Locations |
Not Available
Tissue Location |
Not Available
Pathways |
Not Available
Normal Concentrations |
Not Available |
Abnormal Concentrations |
|
Not Available
Associated Disorders and Diseases |
Disease References |
None
Associated OMIM IDs |
None
External Links |
DrugBank ID |
Not Available
DrugBank Metabolite ID |
Not Available
Phenol Explorer Compound ID |
Not Available
Phenol Explorer Metabolite ID |
Not Available
FoodDB ID |
Not Available
KNApSAcK ID |
Not Available
Chemspider ID |
Not Available
KEGG Compound ID |
Not Available
BioCyc ID |
Not Available
BiGG ID |
Not Available
Wikipedia Link |
Not Available
NuGOwiki Link |
HMDB28920
Metagene Link |
HMDB28920
METLIN ID |
Not Available
PubChem Compound |
Not Available
PDB ID |
Not Available
ChEBI ID |
Not Available
Product: Osalmid
References |
Synthesis Reference |
Not Available |
Material Safety Data Sheet (MSDS) |
Not Available |
General References |
- Suh YJ, Kim BM, Park BH, Park H, Kim YJ, Kim H, Hong YC, Ha EH: Cytochrome P450IA1 polymorphisms along with PM(10) exposure contribute to the risk of birth weight reduction. Reprod Toxicol. 2007 Nov-Dec;24(3-4):281-8. Epub 2007 Jul 7. [PubMed:17706398 ]
- CHEN PF, MALLETTE MF: SYNTHESIS OF THE NEW DIPEPTIDE ISOLEUCYLVALINE BY AN IMPROVEMENT OF METHODS APPLIED TO ALIPHATIC AMINO ACIDS. Nature. 1964 May 9;202:598-9. [PubMed:14195067 ]
- Kammerer S, Burns-Hamuro LL, Ma Y, Hamon SC, Canaves JM, Shi MM, Nelson MR, Sing CF, Cantor CR, Taylor SS, Braun A: Amino acid variant in the kinase binding domain of dual-specific A kinase-anchoring protein 2: a disease susceptibility polymorphism. Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):4066-71. Epub 2003 Mar 19. [PubMed:12646697 ]
- Wang JJ, Zheng Y, Sun L, Wang L, Yu PB, Li HL, Tian XP, Dong JH, Zhang L, Xu J, Shi W, Ma TY: CYP1A1 Ile462Val polymorphism and susceptibility to lung cancer: a meta-analysis based on 32 studies. Eur J Cancer Prev. 2011 Nov;20(6):445-52. doi: 10.1097/CEJ.0b013e328345f937. [PubMed:22025136 ]
- Bulaj G, Otlewski J: Ligand-induced changes in the conformational stability of bovine trypsinogen and their implications for the protein function. J Mol Biol. 1995 Apr 7;247(4):701-16. [PubMed:7723025 ]
|
PMID: 9566817